RT Journal Article
SR Electronic
T1 Characterization of an extreme phenotype of schizophrenia among women with homelessness
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.29.23293378
DO 10.1101/2023.07.29.23293378
A1 Menon, Jayakumar
A1 Kantipudi, Suvarna Jyothi
A1 Mani, Aruna
A1 Radhakrishnan, Rajiv
YR 2023
UL http://medrxiv.org/content/early/2023/08/05/2023.07.29.23293378.abstract
AB Background Studies of schizophrenia and homelessness are often confounded by comorbid substance use. Women with schizophrenia and homelessness in India have very low rates of substance use and provide a unique opportunity to disentangle the effects of illness from that of substance use. We examined the clinical characteristics of women with schizophrenia and homelessness and compared it to an age-matched group of women with schizophrenia living with their family.Methods 36 women with schizophrenia and homelessness, and 32 women with schizophrenia who were illness living with family were evaluated for psychopathology using Scale for Assessment of Positive Symptoms (SAPS)/ Scale for assessment of negative symptoms (SANS) scales, cognitive difficulties using Montreal Cognitive Assessment (MOCA)/Rowland Universal Dementia Scale (RUDAS), and Frontal Assessment Battery(FAB), disability using World Health Organization - Disability assessment Scale (WHO-DAS) and psychosocial factors using a semi-structured proforma. The groups were compared using t-tests and chi-square for continuous and categorical variables respectively.Results Women with schizophrenia and homelessness were found to have significantly higher scores on measures of psychopathology, significantly lower cognitive functioning, and much higher disability, and were also on higher doses of antipsychotics. The mean scores on measures of psychopathology, cognition and disability for women with schizophrenia and homelessness differed by 2-3 standard deviations with the mean for women living with family (i.e. z scores) suggesting that they represented an extreme phenotype. Rates of past employment were higher among women with schizophrenia and homelessness. Hence these differences were not accounted for by premorbid functioning.Conclusions The study raises the possibility of an extreme phenotype of schizophrenia with severe and persistent psychopathology non-responsive to dopamine blocking drugs, cognitive impairment, and disability, which needs further exploration.Competing Interest StatementRajiv Radhakrishnan is funded by VA National Center on Homelessness Among Veterans (RFQ36C24820Q1276), National Institute of Mental Health (NIMH) (R21MH123870) National Institute of Drug Abuse (NIDA), National Center for Complementary and Integrative Health (NCCIH) and has received research support from GW Pharmaceuticals (Jazz Pharmaceuticals) and Neurocrine Biosciences. The views expressed are those of the authors and not of those of the federal government or funding agencies. Jayakumar Menon has worked as sub-investigator in a multi-national drug trial by Pfizer. Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics Committee, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Chennai (Ref:IEC/NI/20/OCT/76/99)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors